<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26-vaccines-08-00142">
 <label>26.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kalinke</surname>
    <given-names>U.</given-names>
   </name>
   <name>
    <surname>Oxenius</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>López-Macías</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Zinkernagel</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Hengartner</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Virus neutralization by germ-line vs. hypermutated antibodies</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>2000</year>
  <volume>97</volume>
  <fpage>10126</fpage>
  <lpage>10131</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.97.18.10126</pub-id>
  <pub-id pub-id-type="pmid">10963674</pub-id>
 </element-citation>
</ref>
